The worry here is that someone knows more than we do. I hope it he’ll not but management have made many mistakes in the past, I just hope they aren’t looking after an institution here.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%